Index -
P/E -
EPS (ttm) -1.23
Insider Own 12.98%
Shs Outstand 24.14M
Perf Week 4.77%
Market Cap 2.41B
Forward P/E 14.91
EPS next Y 6.64
Insider Trans -35.38%
Shs Float 21.20M
Perf Month -4.18%
Income -29.66M
PEG -
EPS next Q 0.82
Inst Own 89.43%
Short Float 5.67%
Perf Quarter 6.63%
Sales 2.26B
P/S 1.07
EPS this Y -30.14%
Inst Trans -3.30%
Short Ratio 4.87
Perf Half Y 1.00%
Book/sh 87.96
P/B 1.13
EPS next Y 40.66%
ROA -0.67%
Short Interest 1.20M
Perf Year -47.23%
Cash/sh 10.45
P/C 9.48
EPS next 5Y 16.00%
ROE -1.41%
52W Range 78.28 - 212.43
Perf YTD -0.70%
Dividend Est. -
P/FCF 29.32
EPS past 5Y -
ROI -0.79%
52W High -53.38%
Beta 0.72
Dividend TTM -
Quick Ratio 1.06
Sales past 5Y 13.31%
Gross Margin 31.39%
52W Low 26.52%
ATR (14) 3.31
Dividend Ex-Date -
Current Ratio 2.53
EPS Y/Y TTM 60.56%
Oper. Margin 1.26%
RSI (14) 51.26
Volatility 2.96% 3.14%
Employees 14000
Debt/Eq 0.80
Sales Y/Y TTM -0.91%
Profit Margin -1.31%
Recom 1.80
Target Price 136.00
Option/Short Yes / Yes
LT Debt/Eq 0.77
EPS Q/Q -9.66%
Payout -
Rel Volume 1.38
Prev Close 98.29
Sales Surprise 2.27%
EPS Surprise 31.66%
Sales Q/Q 1.93%
Earnings May 07 AMC
Avg Volume 246.84K
Price 99.04
SMA20 0.78%
SMA50 -2.01%
SMA200 -10.52%
Trades
Volume 340,489
Change 0.76%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-08-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Mar-18-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$206
Aug-08-19 Downgrade
Raymond James
Strong Buy → Outperform
Oct-17-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Jun-20-17 Downgrade
Sidoti
Buy → Neutral
Mar-11-16 Initiated
Gabelli & Co
Buy
$128
Nov-06-15 Reiterated
ROTH Capital
Buy
$124 → $130
Aug-11-15 Reiterated
ROTH Capital
Buy
$102 → $124
May-06-15 Reiterated
ROTH Capital
Buy
$96 → $102
Feb-10-15 Reiterated
ROTH Capital
Buy
$82 → $96
Nov-11-14 Upgrade
ROTH Capital
Neutral → Buy
$56 → $82
May-09-13 Downgrade
The Benchmark Company
Buy → Hold
Sep-27-12 Reiterated
The Benchmark Company
Buy
$60 → $69
Apr-12-12 Initiated
The Benchmark Company
Buy
$60
Sep-26-11 Reiterated
Ticonderoga
Buy
$52 → $49
Oct-29-09 Initiated
C.K. Cooper
Buy
$45
Oct-08-09 Initiated
Roth Capital
Hold
$40
Mar-05-09 Initiated
Northland Securities
Outperform
May-02-08 Initiated
Jesup & Lamont
Buy
$35
Show Previous Ratings
Apr-23-24 08:30AM
Mar-13-24 08:30AM
Mar-05-24 11:41PM
Mar-01-24 05:15PM
Feb-28-24 07:48PM
(Morningstar Research) +5.31%
09:49AM
Loading…
09:49AM
09:36AM
(Thomson Reuters StreetEvents)
Feb-27-24 06:20PM
05:21PM
(Associated Press Finance)
04:36PM
04:05PM
Feb-20-24 10:00AM
Feb-14-24 11:18PM
Feb-13-24 09:02AM
08:30AM
06:28PM
Loading…
Nov-27-23 06:28PM
Nov-07-23 10:36AM
Nov-06-23 11:37PM
05:23PM
05:17PM
(Associated Press Finance)
04:05PM
Oct-27-23 09:06PM
Oct-23-23 08:30AM
Sep-25-23 08:40AM
Sep-12-23 01:01AM
Sep-05-23 08:30AM
Sep-04-23 09:34AM
Aug-29-23 08:00AM
Aug-09-23 07:01AM
Aug-08-23 07:36PM
(Morningstar Research) -16.59%
06:31AM
Loading…
06:31AM
(Thomson Reuters StreetEvents)
Aug-07-23 08:13PM
06:40PM
05:31PM
04:05PM
Jul-24-23 08:30AM
Jun-21-23 08:00PM
Jun-20-23 05:13PM
May-10-23 06:09AM
May-09-23 05:25PM
(Morningstar Research) +13.64%
05:57AM
(Thomson Reuters StreetEvents)
May-08-23 05:35PM
04:29PM
04:05PM
Apr-26-23 08:00PM
Apr-24-23 07:56PM
08:30AM
Apr-11-23 07:07AM
Mar-29-23 09:47AM
Mar-15-23 05:55PM
Mar-09-23 08:30AM
Mar-02-23 05:44AM
Mar-01-23 07:11PM
05:15AM
Feb-28-23 11:05AM
06:31AM
(Thomson Reuters StreetEvents)
Feb-27-23 06:15PM
04:05PM
Feb-26-23 08:04AM
Feb-21-23 08:30AM
Feb-13-23 08:30AM
Feb-08-23 08:00AM
Jan-23-23 08:55AM
Jan-20-23 07:21PM
(Morningstar Research) +5.83%
Dec-19-22 08:30AM
Dec-03-22 07:28AM
Nov-07-22 06:35PM
04:05PM
Nov-06-22 07:21AM
Nov-01-22 09:00AM
Oct-31-22 04:01PM
Oct-07-22 10:08AM
Oct-06-22 08:30AM
Sep-26-22 08:18AM
Sep-08-22 08:30AM
Aug-09-22 03:15PM
Aug-08-22 06:15PM
04:05PM
Jul-19-22 08:30AM
Jun-18-22 08:51AM
May-19-22 08:05AM
May-11-22 04:12PM
May-09-22 05:45PM
04:05PM
06:07AM
May-06-22 03:18AM
May-05-22 02:52AM
May-04-22 03:05AM
Apr-20-22 08:30AM
03:35AM
Apr-19-22 07:51AM
02:57AM
Apr-14-22 02:37AM
Apr-13-22 06:54AM
Apr-12-22 02:31AM
Apr-11-22 05:04AM
Apr-08-22 02:37AM
Mar-24-22 08:03AM
Mar-23-22 12:00PM
09:40AM
ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Voigtlander Christian B. Chief Operating Officer Mar 15 '24 Option Exercise 0.00 3,247 0 14,319 Mar 18 04:51 PM Woolson Daniel VP, GM-Infusion Capital Mar 15 '24 Option Exercise 0.00 2,923 0 16,903 Mar 18 04:49 PM Sousa Ben Chief Information Officer Mar 15 '24 Option Exercise 0.00 1,299 0 3,782 Mar 18 04:46 PM Sanzone Virginia Ruth VP, General Counsel Mar 15 '24 Option Exercise 0.00 1,624 0 7,422 Mar 18 04:44 PM Jain Vivek Chairman and CEO Mar 15 '24 Option Exercise 0.00 4,871 0 107,264 Mar 18 04:38 PM Bonnell Brian Michael Chief Financial Officer Mar 15 '24 Option Exercise 0.00 3,247 0 26,734 Mar 18 04:35 PM Woolson Daniel VP, GM-Infusion Capital Mar 15 '24 Sale 98.27 791 77,733 13,980 Mar 15 05:24 PM LOPEZ GEORGE A Director Mar 14 '24 Sale 101.87 7,978 812,741 877,343 Mar 14 06:13 PM LOPEZ GEORGE A Director Mar 12 '24 Sale 101.51 1,522 154,497 316,231 Mar 13 04:09 PM LOPEZ GEORGE A Director Mar 11 '24 Sale 104.22 1,890 196,968 317,753 Mar 13 04:09 PM Sousa Ben Chief Information Officer Mar 08 '24 Option Exercise 0.00 674 0 2,723 Mar 11 04:33 PM Sanzone Virginia Ruth VP, General Counsel Mar 08 '24 Option Exercise 0.00 2,273 0 7,044 Mar 11 04:24 PM Jain Vivek Chairman and CEO Mar 08 '24 Option Exercise 0.00 10,856 0 106,962 Mar 11 04:26 PM Bonnell Brian Michael Chief Financial Officer Mar 08 '24 Option Exercise 0.00 9,499 0 27,485 Mar 11 04:28 PM Voigtlander Christian B. Chief Operating Officer Mar 08 '24 Option Exercise 0.00 9,499 0 15,070 Mar 11 04:32 PM Woolson Daniel VP, GM-Infusion Capital Mar 08 '24 Option Exercise 0.00 2,020 0 15,665 Mar 11 04:35 PM LOPEZ GEORGE A Director Mar 08 '24 Sale 105.94 15,372 1,628,454 319,643 Mar 11 04:22 PM Sanzone Virginia Ruth VP, General Counsel Mar 08 '24 Sale 104.57 3,300 345,088 4,771 Mar 11 04:24 PM Sousa Ben Chief Information Officer Mar 07 '24 Option Exercise 0.00 3,003 0 2,967 Mar 11 04:33 PM Woolson Daniel VP, GM-Infusion Capital Mar 07 '24 Option Exercise 0.00 6,758 0 16,209 Mar 11 04:35 PM Voigtlander Christian B. Chief Operating Officer Mar 07 '24 Option Exercise 0.00 15,017 0 13,842 Mar 11 04:32 PM Bonnell Brian Michael Chief Financial Officer Mar 07 '24 Option Exercise 0.00 15,017 0 26,257 Mar 11 04:28 PM Jain Vivek Chairman and CEO Mar 07 '24 Option Exercise 0.00 22,524 0 108,078 Mar 11 04:26 PM Sanzone Virginia Ruth VP, General Counsel Mar 07 '24 Option Exercise 0.00 7,509 0 11,600 Mar 11 04:24 PM LOPEZ GEORGE A Director Mar 07 '24 Sale 105.77 18,954 2,004,708 335,015 Mar 11 04:22 PM Voigtlander Christian B. Chief Operating Officer Mar 04 '24 Sale 107.19 13,603 1,458,090 0 Mar 05 01:42 PM LOPEZ GEORGE A Director Mar 04 '24 Sale 106.79 7,051 752,993 353,969 Mar 11 04:22 PM Smiths Group International Hol Former 10% Owner Feb 29 '24 Sale 106.08 830,000 88,042,250 1,670,000 Mar 01 04:16 PM SMITHS GROUP PLC Former 10% Owner Feb 29 '24 Sale 106.08 830,000 88,042,250 1,670,000 Mar 01 04:16 PM Jain Vivek Chairman and CEO Feb 12 '24 Option Exercise 58.79 146,366 8,604,857 170,043 Feb 14 04:23 PM Jain Vivek Chairman and CEO Feb 12 '24 Option Exercise 58.79 66,000 3,880,140 126,000 Feb 14 04:23 PM Woolson Daniel VP, GM-Infusion Capital Dec 01 '23 Sale 88.03 1,729 152,196 9,877 Dec 01 05:08 PM Voigtlander Christian B. Chief Operating Officer Sep 08 '23 Sale 129.04 6,850 883,930 13,603 Sep 11 12:27 PM Jain Vivek Chairman and CEO Jul 12 '23 Option Exercise 58.79 30,000 1,763,700 53,677 Jul 14 05:36 PM Jain Vivek Chairman and CEO Jul 12 '23 Sale 180.02 30,000 5,400,720 23,677 Jul 14 05:36 PM Jain Vivek Chairman and CEO Jun 14 '23 Option Exercise 58.79 30,000 1,763,700 31,840 Jun 15 10:22 AM Jain Vivek Chairman and CEO Jun 14 '23 Sale 188.67 30,000 5,660,086 23,677 Jun 15 10:22 AM FINNEY ELISHA W Director Jun 07 '23 Sale 190.41 194 36,940 1,481 Jun 07 04:26 PM Greenberg David C. Director May 17 '23 Option Exercise 0.00 485 0 4,089 May 18 12:15 PM Hernandez Laurie Director May 17 '23 Option Exercise 0.00 485 0 937 May 18 12:19 PM FINNEY ELISHA W Director May 17 '23 Option Exercise 0.00 485 0 1,675 May 18 12:41 PM KENNEDY KOLLEEN T Director May 17 '23 Option Exercise 0.00 485 0 614 May 18 12:51 PM Hoffmeister David F Director May 17 '23 Option Exercise 0.00 485 0 2,079 May 18 12:46 PM Abbey Donald Director May 17 '23 Option Exercise 0.00 485 0 2,079 May 18 12:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite